Applications
- BACTERIA
- BRONCHIAL CARCINOMA
- COPD
- HALITOSIS
- DIALYSIS
- REJECTION PROGNOSIS
- TUMOR TYPE
- HUNTER-SYNDROME ENZYME TREATMENT
- MEDICATION CONTROL
- ANAESTHESIE MONITORING
Within a clinical study the exhaled breath of persons suffering COPD without and with lung cancer and healthy volunteers was investigated using an Ion Mobility Spectrometer coupled to a Multi-Capillary Column without any pre-separation or pre-enrichment. A single analyte was be able to separate the two groups of healthy persons and those such suffering from COPD with and without lung cancer. The sensitivity obtained was 60%, the specificity 91%, the positive predictive value 95%. The peak was characterized as cyclohexanone (CAS 108-94-1). Thus, a concentration of cyclohexanone above the threshold could be seen as an indicator for COPD. The identity of the peak used for separation of the two groups must be validated with a greater population and external standards. Additional studies with a higher population and parallel measurements using GC/MSD will support the identification further.